Dawn Whitehair, APRN
Psychiatric/Mental Health · Brecksville, OHNPI 1760137665
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,500 of the $15,591 with a category attached, or 67.3%. AbbVie accounts for 77.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $12,381, more than ten times the $511 reported in 2022. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $85.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Alkermes, Inc.$466
- Axsome Therapeutics, Inc.$170
- Johnson & Johnson$134
- Vanda Pharmaceuticals Inc.$125
- plus $221 from 4 others
What the payments were for
- Speaking & faculty fees$10,50067%
- Food & beverage$5,09133%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 77 | $12,049 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 81 | $2,425 |
| Alkermes, Inc. | 12 | $466 |
| Axsome Therapeutics, Inc. | 3 | $170 |
| Johnson & Johnson | 2 | $134 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 2 | $117 |
| Lundbeck LLC | 3 | $55 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| Hikma Pharmaceuticals USA | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,591 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $1,636 |
| Escitalopram Oxalate | 84 | $566 |
| Quetiapine Fumarate | 37 | $501 |
| Buspirone Hcl | 18 | $478 |
| Bupropion XlBupropion Hcl | 11 | $346 |
| Duloxetine Hcl | 13 | $343 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 49 | $316 |
| Aripiprazole | 23 | $192 |
| Sertraline Hcl | 21 | $165 |
| Mirtazapine | 23 | $148 |
| Clonazepam | 32 | $105 |
| Zolpidem Tartrate | 12 | $99 |
| Trazodone Hcl | 20 | $72 |
| Lorazepam | 11 | $46 |
| Diazepam | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Brecksville
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
- Danielle MorroneCanfield$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.